Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: TimF who wrote (3353)	12/18/2007 7:12:12 AM
From: Road Walker	Read Replies (1) \| Respond to of 42652

Exactly. The US System is paying for it. When a German drug company develops a drug knowing it can make a ton of profit in the US market if the drug turns out to be safe and effective, its the US system providing a disproportionate part of the return on investment that motivates the spending on research and provides funds for further research. How much research are the insurance companies paying for? We're talking about a payment system. The majority of drug and procedure research is paid for by the government and research institutions, not the drug companies and certainly not the insurance companies. Much of the money comes from charity. It is done by academics... To assume that if we go to a single payer system that there will be vastly lower investment in medical research is just false. Even a slight decrease in drug company R&D is probably a stretch.